Skip to main content
KO
NYSE Manufacturing

Coca-Cola Reports Solid Q4 & Full Year 2025 Results, Issues Positive 2026 Outlook Despite BODYARMOR Impairment

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Food & Beverage Stocks · Consumer
Sentiment info
Neutral
Importance info
7
Price
$76.48
Mkt Cap
$335.396B
52W Low
$63.27
52W High
$79.2
52W Position info
21% above low
Off High info
3.4% below high
Rel. Volume info
1.3× avg
Market data snapshot near publication time

KO sits 21% above its 52-week low of $63.27.

Summary

Coca-Cola reported strong underlying Q4 and full year 2025 results with positive 2026 guidance, though reported operating income was impacted by a non-cash BODYARMOR trademark impairment.


Key Events · Earnings and Guidance · KO

  • Q4 and Full Year 2025 Financial Performance

    For Q4 2025, net revenues grew 2% (5% organic) and comparable EPS increased 6%. For the full year 2025, net revenues grew 2% (5% organic) and comparable EPS increased 4% to $3.00. The company gained value share in total nonalcoholic ready-to-drink beverages for both periods.

  • BODYARMOR Trademark Impairment Charge

    A non-cash impairment charge of $960 million related to the BODYARMOR trademark significantly impacted reported Q4 2025 operating income, which declined 32%. However, comparable currency neutral operating income grew 13% for the quarter.

  • Strong Free Cash Flow Generation

    Full year 2025 cash flow from operations was $7.4 billion, with free cash flow (excluding a fairlife contingent payment) reaching $11.4 billion, demonstrating robust liquidity.

  • Positive 2026 Financial Outlook

    The company projects 4-5% organic revenue growth and 7-8% comparable EPS growth for full year 2026, alongside an expected free cash flow of approximately $12.2 billion.


Analysis · KO · Manufacturing

The Coca-Cola Company's 8-K filing details its fourth quarter and full year 2025 financial performance and provides a positive outlook for 2026. While reported operating income for Q4 2025 saw a significant decline due to a $960 million non-cash impairment charge related to the BODYARMOR trademark, the underlying business demonstrated resilience with strong organic revenue growth and comparable EPS expansion. The company's guidance for 2026, including projected organic revenue growth of 4-5% and comparable EPS growth of 7-8%, indicates continued operational strength. The robust free cash flow generation further supports the company's financial health. This report comes as the stock trades near its 52-week high, suggesting investor confidence in its long-term strategy despite specific non-recurring charges.

At the time of this filing, KO was trading at $76.48 on NYSE in the Manufacturing sector, with a market capitalization of approximately $335.4B. The 52-week trading range was $63.27 to $79.20. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

KO - Latest Insights

KO
Jul 27, 2026, 6:55 AM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $82.08
Real-time Price: $82.98 info
Change: +$0.900 (+1%) info
Market Cap: $353.879B info
KO
Jul 21, 2026, 5:07 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $81.97
Real-time Price: $82.98 info
Change: +$1.01 (+1%) info
Market Cap: $353.879B info
KO
Jul 16, 2026, 4:23 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $83.90
Real-time Price: $82.98 info
Change: -$0.920 (-1%) info
Market Cap: $353.879B info
KO
Jul 16, 2026, 4:20 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $83.75
Real-time Price: $82.98 info
Change: -$0.7712 (-0.92%) info
Market Cap: $353.879B info
KO
Jun 25, 2026, 4:19 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $80.42
Real-time Price: $82.98 info
Change: +$2.56 (+3%) info
Market Cap: $353.879B info